Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gravity Defyer is a private U.S. footwear company that sells comfort, orthotic, and supportive shoes under the GDEFY brand. Its products are marketed for walking, work, running, and everyday use, with a focus on shock absorption, arch alignment, stability support, and all-day comfort. The company’s core branded technology is VersoShock, which it integrates across multiple shoe lines such as Mighty Walk, ION, Energiya, and XLR8 Run. Although the business uses medical and pain-relief positioning in its marketing, it is fundamentally a consumer footwear and e-commerce company rather than a drug developer or life sciences company. For biotech/pharma classification purposes, Gravity Defyer is best treated as a commercial orthopedic/supportive footwear brand, not a therapeutic biotech or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gravity Defyer.